Gage Cannabis Announces Limited Edition Everybody Vs Injustice Merchandise to Support the Detroit Justice Center
DETROIT, Nov. 1, 2021 /CNW/ - Gage Growth Corp. ("Gage" or the "Company") (CSE: GAGE), a leading high-quality premium cannabis brand and operator in Michigan, today announced its upcoming campaign against injustice with world renown Detroit Vs Everybody, LLC ("DVE").
Starting this Fall, the Company will release a limited-edition capsule collection of DVE's "EVERYBODY VS INJUSTICE" branded merchandise, including T-shirts, long sleeves, sweaters, hats and small accessories. The merchandise was specially designed by DVE for Gage to support those whose lives have been up-ended by cannabis prohibition. Net profits from merchandise retail sales will be donated to the Detroit Justice Center, a non-profit law firm working alongside communities to create economic opportunities, and to promote social equity and justice.
Although 40% of Americans currently live in a state where cannabis is fully legal, discriminatory policies perpetuated by the War on Drugs are still heavily enforced within communities of color. The EVERYBODY VS INJUSTICE campaign is part of the Company's ongoing efforts to support the advancement of individuals and groups that have been adversely impacted by cannabis prohibition. Last year, Gage launched a social equity program that awards grants of up to $50,000 to cannabis entrepreneurs in 19 social equity cities designated by the Michigan Marijuana Regulatory Agency.
"Our community of patients and consumers in Michigan is the driving force behind Gage's continued success, and we recognize our unique responsibility to make a positive social and economic impact as industry leaders," said Fabian Monaco, CEO of Gage. "It has been a privilege to work with Tommey Walker and the rest of the DVE team to create an exclusive line that gives back to the extraordinary city of Detroit."
"DETROIT VS EVERYBODY exists to inspire Everybody to persist rather than quit, to contribute rather than complain, to unify rather than divide and to innovate rather than duplicate. Our entire team is grateful for Gage's ongoing support in our fight against social injustice," said Tommey Walker, Founder of Detroit Vs Everybody. "Our combined platforms will raise awareness and funds, while inspiring EVERYBODY to stand against the unjust legacy of cannabis policies."
EVERYBODY VS INJUSTICE merchandise will be available at all Gage and Cookies retail locations starting November 12, 2021.
Gage Growth Corp. is innovating and curating the highest quality cannabis experiences possible for cannabis consumers in the state of Michigan and bringing internationally renowned brands to market. Through years of progressive industry experience, the firm's founding partners have successfully built and grown operations with federal and state licenses, including cultivation, processing and retail locations. Gage's portfolio includes city and state approvals for 19 "Class C" cultivation licenses, three processing licenses and 15 provisioning centers (dispensaries).
Instagram: @gagecannabis Facebook: @gageusa Twitter: @gagecannabisco
About Detroit Vs Everybody, LLC
DVE, was founded by Detroit native son Tommey Walker, a graphic artist by training whocombines streetwear cool with social impact since inception - long before social impact became a hot topic. DVE collaborates with major professional sports leagues, leading automakers and world renown musicians such as, for example, General Motors and Eminem. Most recently, DVE partnered with Gucci to support The Gucci Changemakers social impact fund.
"DETROIT VS EVERYBODY," "EVERYBODY VS," AND "VS EVERYBODY" are the registered trademarks of "Detroit Vs Everybody, LLC. For more information about DVE and Tommey Walker visit:www.detroitvseverybody.com, and www.tommeywalker.com.
Caution Regarding Cannabis Operations in the United States
Investors should note that there are significant legal restrictions and regulations that govern the cannabis industry in the United States. While legal in certain states, cannabis remains a Schedule I drug under the U.S. Controlled Substances Act, making it illegal under federal law in the United States to, among other things, cultivate, distribute or possess cannabis. Financial transactions involving proceeds generated by, or intended to promote, cannabis-related business activities in the United States may form the basis for prosecution under applicable U.S. federal money laundering legislation. Investors should carefully read the risk factors and disclosures contained in the offering circular prepared in connection with the Offering before making any decision to invest in the Company.
Explanatory Note Regarding the Company's Operations
References in this news release to the Company and its operations and portfolio are inclusive of the operations and assets of certain licensed cannabis operators that operate under the Gage brand pursuant to contractual arrangements with the Company. For additional information, please refer to the Company's long form prospectus dated March 26, 2021 and other disclosure documents available on the Company's profile at www.sedar.com.
Forward Looking Information
This news release contains "forward-looking information" within the meaning of applicable securities laws. Forward-looking information contained in this press release may be identified by the use of words such as, "may", "would", "could", "will", "likely", "expect", "anticipate", "believe, "intend", "plan", "forecast", "project", "estimate", "outlook" and other similar expressions, and include statements with respect to future growth. Forward-looking information is not a guarantee of future performance and is based upon a number of estimates and assumptions of management in light of management's experience and perception of trends, current conditions and expected developments, as well as other factors relevant in the circumstances, including assumptions in respect of current and future market conditions, the current and future regulatory environment; and the availability of licenses, approvals and permits.
Although the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. Forward-looking information is subject to a variety of risks and uncertainties that could cause actual events or results to differ materially from those projected in the forward-looking information including, but not limited to, those risks disclosed in the Company's long form prospectus dated March 26, 2021 and other disclosure documents available on the Company's profile at www.sedar.com. The statements in this press release are made as of the date of this release. The Company disclaims any intent or obligation to update any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.
SOURCE Gage Cannabis Co.
For further information: Gage Contact: 1-(833)-455-GAGE (4243), IR@gageusa.com